These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8645677)

  • 41. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
    Anaissie EJ; Vartivarian SE; Abi-Said D; Uzun O; Pinczowski H; Kontoyiannis DP; Khoury P; Papadakis K; Gardner A; Raad II; Gilbreath J; Bodey GP
    Am J Med; 1996 Aug; 101(2):170-6. PubMed ID: 8757357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antifungal susceptibility for Candida albicans isolated from AIDS patients with oropharyngeal and esophageal candidiasis: experience with Etest].
    Tapia C; González P; Pereira A; Pérez J; Noriega LM; Palavecino E
    Rev Med Chil; 2003 May; 131(5):515-9. PubMed ID: 12879812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].
    Wildfeuer A; Laufen H; Yeates RA; Zimmermann T
    Mycoses; 1996; 39 Suppl 1():123-6. PubMed ID: 8767284
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
    Cobo Reinoso P; Aguado García JM; Lumbreras Bermejo C; Pérez Vela JL; Caballero Cubedo R; Sanz Sanz F; Noriega Rodríguez AR
    Rev Clin Esp; 1997 Dec; 197(12):799-803. PubMed ID: 9477669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.
    Akova M; Akalin HE; Uzun O; Hayran M; Tekuzman G; Kansu E; Aslan S; Telatar H
    Clin Infect Dis; 1994 Mar; 18(3):298-304. PubMed ID: 8011807
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
    Phillips P; Shafran S; Garber G; Rotstein C; Smaill F; Fong I; Salit I; Miller M; Williams K; Conly JM; Singer J; Ioannou S
    Eur J Clin Microbiol Infect Dis; 1997 May; 16(5):337-45. PubMed ID: 9228472
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients.
    Abele-Horn M; Kopp A; Sternberg U; Ohly A; Dauber A; Russwurm W; Büchinger W; Nagengast O; Emmerling P
    Infection; 1996; 24(6):426-32. PubMed ID: 9007589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
    J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Colonization of the oral cavity by yeasts in patients with chronic renal failure undergoing hemodialysis.
    Godoy JS; de Souza Bonfim-Mendonça P; Nakamura SS; Yamada SS; Shinobu-Mesquita C; Pieralisi N; Fiorini A; Svidzinski TI
    J Oral Pathol Med; 2013 Mar; 42(3):229-34. PubMed ID: 22978344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fluconazole in the treatment of oropharyngeal candidosis in HIV-positive patients.
    Just-Nübling G; Gentschew G; Döhle M; Böttinger C; Helm EB; Stille W
    Mycoses; 1990; 33(9-10):435-40. PubMed ID: 2093839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
    Carrillo-Muñoz AJ; Quindós G; Ruesga M; Alonso R; del Valle O; Hernández-Molina JM; McNicholas P; Loebenberg D; Santos P
    J Antimicrob Chemother; 2005 Mar; 55(3):317-9. PubMed ID: 15705637
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Oropharyngeal candidiasis resistant to fluconazole in patients infected by HIV].
    Drobacheff C; Manteaux A; Millon L; Reboux G; Barale T; Laurent R
    Ann Dermatol Venereol; 1996; 123(2):85-9. PubMed ID: 8761757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
    Ellepola AN; Samaranayake LP
    Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of prophylactic fluconazole on the frequency of fungal infections, amphotericin B use, and health care costs in patients undergoing intensive chemotherapy for hematologic neoplasias.
    Schaffner A; Schaffner M
    J Infect Dis; 1995 Oct; 172(4):1035-41. PubMed ID: 7561177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for oropharyngeal candidiasis in patients who receive radiation therapy for malignant conditions of the head and neck.
    Epstein JB; Freilich MM; Le ND
    Oral Surg Oral Med Oral Pathol; 1993 Aug; 76(2):169-74. PubMed ID: 8361726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.
    Darouiche RO
    Clin Infect Dis; 1998 Feb; 26(2):259-72; quiz 273-4. PubMed ID: 9502438
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.